BDNF and depressive symptom measurement: A longitudinal analysis by Jae-Min Ki et al. highlighted a direct correlation between elevated BDNF methylation percentages and PSD incidence, suggesting that heightened methylation might suppress BDNF secretion post-stroke, thereby elevating depression risk.